Clinical Trial Update: Evaluate Safety and Immunogenicity of a Vero Cell-Derived JE Vaccine in 9-24 Months of Age Children in Vietnam [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating safety and immunogenicity of a Vero cell–derived Japanese Encephalitis vaccine in children 9-24 months in Vietnam has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis

Drugs mentioned

• Vero Cell-derived Japanese Encephalitis Vaccine (Japanese encephalitis vaccine (Vero cell-derived))

Snippet

Sponsor: National Institute of Hygiene and Epidemiology, Vietnam | Conditions: Japanese Encephalitis | Phase 3 | Status: COMPLETED